Comparison between Carraro India IPO and Senores Pharmaceuticals IPO.
Carraro India IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Senores Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Carraro India IPO is up to ₹1,250.00 Cr whereas the issue size of the Senores Pharmaceuticals IPO is up to ₹582.11 Cr. The final issue price of Carraro India IPO is ₹704.00 per share and of Senores Pharmaceuticals IPO is ₹391.00 per share.
| Carraro India IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹668.00 per share | ₹372.00 per share |
| Issue Price (Upper) | ₹704.00 per share | ₹391.00 per share |
| Issue Price (Final) | ₹704.00 per share | ₹391.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 21 shares | 38 shares |
| Fresh Issue Size | 0 shares | 1,27,87,723 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹500.00 Cr |
| OFS Issue Size | 1,77,55,681 shares | 21,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,250.00 Cr | up to ₹82.11 Cr |
| Issue Size Total | 1,77,55,681 shares | 1,48,87,723 shares |
| Issue Size Total (Amount) | up to ₹1,250.00 Cr | up to ₹582.11 Cr |
Carraro India IPO opens on Dec 20, 2024, while Senores Pharmaceuticals IPO opens on Dec 20, 2024. The closing date of Carraro India IPO and Senores Pharmaceuticals IPO is Dec 24, 2024, and Dec 24, 2024, respectively.
| Carraro India IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2024 | Dec 19, 2024 |
| Issue Open | Dec 20, 2024 | Dec 20, 2024 |
| Issue Close | Dec 24, 2024 | Dec 24, 2024 |
| Basis Of Allotment (Tentative) | Dec 26, 2024 | Dec 26, 2024 |
| Initiation of Refunds (Tentative) | Dec 27, 2024 | Dec 27, 2024 |
| Credit of Share (Tentative) | Dec 27, 2024 | Dec 27, 2024 |
| Listing date (Tentative) | Dec 30, 2024 | Dec 30, 2024 |
| Anchor Lockin End date 1 | Jan 24, 2025 | Jan 24, 2025 |
| Anchor Lockin End date 2 | Mar 25, 2025 | Mar 25, 2025 |
Carraro India IPO P/E ratio is 63.97, as compared to Senores Pharmaceuticals IPO P/E ratio of 39.77.
| Carraro India IPO | Senores Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 66.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.77 | 45.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 63.97 | 39.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹4002.35 Cr. | ₹1350.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 17.69% | 23.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.35% | 11.73% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.58 | 1.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.00 | ₹9.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.92% | 23.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Carraro India IPO Retail Individual Investors (RII) are offered 62,14,489 shares while in Senores Pharmaceuticals IPO retail investors are offered 62,14,489 shares. Qualified Institutional Buyers (QIB) are offered 35,51,136 shares in Carraro India IPO and 44,43,818 shares in Senores Pharmaceuticals IPO.
| Carraro India IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 53,26,703 shares | 66,65,725 shares |
| Market Maker Reservation | ||
| QIB | 35,51,136 shares | 44,43,818 shares |
| NII | 26,63,353 shares | 22,21,908 shares |
| RII | 62,14,489 shares | 14,81,272 shares |
| Employee | 75,000 shares | |
| Others | ||
| Total | 1,77,55,681 shares | 1,48,87,723 shares |
Carraro India IPO subscribed 1.18x in total, whereas Senores Pharmaceuticals IPO subscribed 97.86x.
| Carraro India IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 2.33x | 97.84x |
| NII (times) | 0.63x | 100.35x |
| Big NII (times) | 0.45x | 95.25x |
| Small NII (times) | 1.01x | 111.35x |
| RII (times) | 0.75x | 93.16x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.18x | 97.86x |
